StockNews.com开始报道Heska（NASDAQ：HSKA）

StockNews.com started coverage on shares of Heska (NASDAQ:HSKA – Get Rating) in a research report released on Friday. The firm issued a hold rating on the medical research company's stock.

Several other research analysts also recently weighed in on HSKA. Alliance Global Partners downgraded shares of Heska from a buy rating to a neutral rating in a research report on Monday, April 3rd. Piper Sandler decreased their price target on shares of Heska from $165.00 to $150.00 in a research report on Thursday, March 2nd. Finally, Morgan Stanley increased their price target on shares of Heska from $58.00 to $120.00 and gave the stock an equal weight rating in a research report on Tuesday, April 4th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Heska has a consensus rating of Hold and a consensus target price of $137.25.

Heska Stock Up 0.1 %

Shares of Heska stock opened at $117.47 on Friday. The company has a market cap of $1.28 billion, a price-to-earnings ratio of -60.86 and a beta of 1.59. The company's 50 day moving average is $95.74 and its 200 day moving average is $79.78. Heska has a twelve month low of $57.83 and a twelve month high of $132.44. The company has a quick ratio of 5.18, a current ratio of 6.70 and a debt-to-equity ratio of 0.23.

Heska (NASDAQ:HSKA – Get Rating) last issued its quarterly earnings data on Tuesday, February 28th. The medical research company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.05. The company had revenue of $66.34 million for the quarter, compared to the consensus estimate of $63.96 million. Heska had a negative net margin of 7.73% and a positive return on equity of 0.57%. Research analysts anticipate that Heska will post 0.3 EPS for the current year.

Institutional Trading of Heska

Several institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. raised its position in shares of Heska by 1.1% during the 1st quarter. BlackRock Inc. now owns 1,848,182 shares of the medical research company's stock valued at $255,566,000 after purchasing an additional 19,589 shares during the period. Vanguard Group Inc. raised its position in shares of Heska by 3.1% during the 1st quarter. Vanguard Group Inc. now owns 708,078 shares of the medical research company's stock valued at $97,913,000 after purchasing an additional 21,203 shares during the period. State Street Corp raised its position in shares of Heska by 0.5% during the 3rd quarter. State Street Corp now owns 386,864 shares of the medical research company's stock valued at $28,210,000 after purchasing an additional 1,968 shares during the period. Grandeur Peak Global Advisors LLC raised its position in shares of Heska by 14.7% during the 3rd quarter. Grandeur Peak Global Advisors LLC now owns 252,154 shares of the medical research company's stock valued at $18,387,000 after purchasing an additional 32,226 shares during the period. Finally, Bank of America Corp DE raised its position in shares of Heska by 23.2% during the 4th quarter. Bank of America Corp DE now owns 248,411 shares of the medical research company's stock valued at $15,441,000 after purchasing an additional 46,728 shares during the period. 99.01% of the stock is currently owned by institutional investors.

About Heska

(Get Rating)

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland.

Read More

• Get a free copy of the StockNews.com research report on Heska (HSKA)
• MarketBeat Week in Review – 4/17 – 4/21
• 2 Industrial Strength Dividend Stocks Melting Up
• Proctor & Gamble Is Going To Set A New High
• AutoNation's Plans are Keeping Analysts Around
• Netflix Increases Buybacks: Can It Complete A Reversal In 2023?

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.